Barclays PLC Portfolio Holdings

Barclays PLC

  • $436 Billion
  • Q2 2025

Barclays PLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $436 Billion distributed in 12350 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $17.4B, Nvidia Corp with a value of $15.9B, Apple Inc. with a value of $9.34B, Amazon Com Inc with a value of $7.98B, and Tesla, Inc. with a value of $6.51B.

Examining the 13F form we can see an increase of $184B in the current position value, from $252B to 436B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $436 Billion
ETFs: $158 Billion
Technology: $99.7 Billion
Consumer Cyclical: $34.9 Billion
Financial Services: $33.3 Billion
Communication Services: $27 Billion
Industrials: $20.8 Billion
Healthcare: $20 Billion
Consumer Defensive: $11.9 Billion
Other: $21.9 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$20.6M
$3,000 0.0% of portfolio
11,103
Q2 2025 Reduced 91.4%
$8.8B
$14.6 Million 0.0% of portfolio
93,476
Q2 2025 Reduced 29.99%
$264M
$509,000 0.0% of portfolio
153,828
Q2 2025 Added 85.43%
$9.65B
$21.6 Million 0.0% of portfolio
515,006
Q2 2025 Added 55.81%
$2.01B
$5.21 Million 0.0% of portfolio
486,751
Q2 2025 Added 86.81%
$679M
$1.26 Million 0.0% of portfolio
406,558
Q2 2025 Added 79.76%
$1.72B
$7.53 Million 0.0% of portfolio
97,766
Q2 2025 Added 165.47%
$3.39B
$9.18 Million 0.0% of portfolio
139,378
Q2 2025 Added 79.52%
$1.59B
$13.6 Million 0.0% of portfolio
1,254,098
Q2 2025 Added 86.85%
$3.71B
$21.5 Million 0.0% of portfolio
865,416
Q2 2025 Reduced 2.15%
$4.53B
$8.52 Million 0.0% of portfolio
98,202
Q2 2025 Added 56.32%
$482M
$1.23 Million 0.0% of portfolio
94,793
Q2 2025 Added 99.45%
$868M
$2.01 Million 0.0% of portfolio
246,670
Q2 2025 Added 34.99%
$1.02B
$5.53 Million 0.0% of portfolio
394,041
Q2 2025 Added 102.31%
$2.23B
$2.29 Million 0.0% of portfolio
535,229
Q2 2025 Added 44.44%
$1B
$3.5 Million 0.0% of portfolio
892,707
Q2 2025 Added 101.4%
$519M
$822,000 0.0% of portfolio
85,503
Q2 2025 Added 69.48%
Ares Acquisition Corp Ii
-
$1.13 Million 0.0% of portfolio
-
Q2 2025 New
$0
$11.6 Million 0.0% of portfolio
527,018
Q2 2025 Added 88.53%
$263M
$417,000 0.0% of portfolio
87,581
Q2 2025 Added 63.15%
Ares Management Corporation
-
$392,000 0.0% of portfolio
-
Q2 2025 Reduced 95.44%
$3.31B
$8.63 Million 0.0% of portfolio
39,167
Q2 2025 Added 122.58%
$40.6B
$1.37 Million 0.0% of portfolio
2,486
Q2 2025 Reduced 2.59%
$583M
$1.43 Million 0.0% of portfolio
164,854
Q2 2025 Added 105.92%
Aris Mng Corp
-
$1.97 Million 0.0% of portfolio
-
Q2 2025 Added 746.36%
$611M
$1.51 Million 0.0% of portfolio
63,722
Q2 2025 Added 98.2%
$0
$19.6 Million 0.0% of portfolio
278,685
Q2 2025 Added 351.11%
$0
$379,000 0.0% of portfolio
15,601
Q2 2025 Reduced 57.11%
$611M
$698,000 0.0% of portfolio
165,116
Q2 2025 Added 17.73%
$1.59B
$3.99 Million 0.0% of portfolio
235,295
Q2 2025 Added 50.63%
$501M
$1.7 Million 0.0% of portfolio
248,160
Q2 2025 Added 16.95%
Armlogi Holding Corp
-
$0 0.0% of portfolio
-
Q1 2025 New
Armour Residential Reit Inc
-
$2.65 Million 0.0% of portfolio
-
Q2 2025 Added 59.36%
$8.86B
$7.64 Million 0.0% of portfolio
47,023
Q2 2025 Added 15.16%
$145M
$284,000 0.0% of portfolio
52,831
Q2 2025 Added 81.15%
$1.18B
$5.09 Million 0.0% of portfolio
862,848
Q2 2025 Reduced 21.69%
Arrive Ai Inc
-
$34,000 0.0% of portfolio
-
Q2 2025 New
Arrivent Biopharma Inc
-
$2.55 Million 0.0% of portfolio
-
Q2 2025 Added 188.82%
$7.64B
$5.89 Million 0.0% of portfolio
46,199
Q2 2025 Reduced 43.47%
$481M
$715,000 0.0% of portfolio
27,060
Q2 2025 Added 64.29%
$3.08B
$6.47 Million 0.0% of portfolio
409,603
Q2 2025 Added 77.98%
$0
$10.9 Million 0.0% of portfolio
622,235
Q2 2025 Added 371.27%
$290M
$450,000 0.0% of portfolio
47,302
Q2 2025 Added 50.61%
$280M
$44,000 0.0% of portfolio
1,299
Q1 2025 New
$3.04B
$17.4 Million 0.0% of portfolio
392,166
Q2 2025 Added 7.09%
Artiva Biotherapeutics Inc
-
$3,000 0.0% of portfolio
-
Q2 2025 Reduced 91.62%
$1.59B
$2.31 Million 0.0% of portfolio
74,136
Q2 2025 Added 44.5%
$405M
$1.63 Million 0.0% of portfolio
220,833
Q2 2025 Added 57.89%
$1.72B
$7.02 Million 0.0% of portfolio
520,074
Q2 2025 Added 93.89%

Summary

  • Portfolio
  • No. of Stocks 12,350
  • Current Value $436 Billion
  • Prior Value $252 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR/A
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email